Herman Mary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 By Steve Blechman
 
A new study published, November 23, 2020, in the journal Cell Metabolism found that giving insulin to type 2 diabetics infected with the coronavirus increased mortality and death. According to the researchers, “COVID-19 caused by SARS-CoV-2 infection can lead to multi-organ injuries and significant mortality in severe and critical patients, especially among those individuals with type 2 diabetes (T2D) as a comorbidity. While attenuated mortality was observed with aggressive glucose control, it was unclear whether therapeutic regimens including insulin treatment were beneficial for patients with COVID-19 and T2D. This retrospective study investigated 689 patients with COVID-19 and T2D from a cohort of 3,305 cases from Wuhan, China. Unexpectedly, we found that insulin treatment for patients with COVID-19 and T2D was associated with a significant increase in mortality (27.2% versus 3.5%; adjusted HR, 5.38 [2.75-10.54]). Further analysis showed that in ....

United States , Shane Hovertsen , Kevin Levrone , Schelomo Marmor , David Ludwig , Herman Mary , Flex Wheeler , Steve Blechman , Jessica Gronski , Ann Pediatr Endocrinol , Nicholase Ingraham , Shawn Ray , Thomasa Murray , Olympia Dorian Yates , Carolynt Bramante , Rotellac Monami , Lee Haney , Frank Zane , Muscular Development , Sandoz International , American Diabetes Association , University Of Kentucky , Cell Metabolism , Aging Cell , Clinical Endocrinology , New York Times ,